During the past decade, Cleveland Clinic - Taussig Cancer Center conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 117 clinical trials were completed, i.e. on average, 164.8% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 31 clinical trials were completed. i.e. 119.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic - Taussig Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 92 trials, followed by "Radiation Therapy Oncology Group" with 52 trials sponsored, "Children's Oncology Group" with 48 trials sponsored, "Gynecologic Oncology Group" with 42 trials sponsored and "Eastern Cooperative Oncology Group" with 42 trials sponsored. Other sponsors include 219 different institutions and companies that sponsored additional 110 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic - Taussig Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 329 trials as a collaborator, "Cancer and Leukemia Group B" with 19 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator and "Eastern Cooperative Oncology Group" with 16 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic - Taussig Cancer Center" are "Leukemia" (40 trials), "Lymphoma" (40 trials), "Lung Cancer" (37 trials), "Brain and Central Nervous System Tumors" (31 trials) and "Sarcoma" (27 trials). Many other conditions were trialed in "Cleveland Clinic - Taussig Cancer Center" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic - Taussig Cancer Center" are "Drug" (396 trials), "Biological" (122 trials), "Radiation" (115 trials), "Procedure" (84 trials) and "Other" (36 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (82 trials), "cisplatin" (46 trials), "filgrastim" (45 trials), "cyclophosphamide" (44 trials) and "paclitaxel" (39 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic - Taussig Cancer Center" are 378 trials for "All" genders, 74 trials for "Female" genders and 26 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic - Taussig Cancer Center". undefined are not yet recruiting, 17 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 335 completed trials in Cleveland Clinic - Taussig Cancer Center, 1 suspended trials, and 68 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic - Taussig Cancer Center, 87 "Phase 1" clinical trials were conducted, 249 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".